CSK and neoplasm: The SFKs include the non-receptor tyrosine kinase C-terminal Src kinase (CSK), which plays a pivotal role in tumour progression and suppression by inhibiting SFK oncogenic effects in several cancer types (Okada et al., 1991; Nakagawa et al., 2000; Cui et al., 2019).